Prolacta Bioscience
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Prolacta Bioscience sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Prolacta Bioscience: 7 sponsored US clinical trials, none currently recruiting.
Prolacta Bioscience sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 5 completed. 0 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Infant, Very Low Birth Weight, with 1 trials.
Upper-quartile sponsor footprint
Prolacta Bioscience sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
7 total, page 1 of 1
Study To Evaluate The Safety And Efficacy of PBCLN-010 In Combination With PBCLN-014 in Participants Receiving Allogeneic Hematopoietic Cell Transplantation
NCT06102213
Dietary Supplement With and Without a Probiotic and/or Antibiotic
NCT05141903
Dietary Supplement With and Without a Probiotic
NCT04433208
A Study of Safety of PBCLN-003 Following Antibiotic Therapy in Subjects With C.Difficile-associated Diarrhea
NCT03793686
Safety Study of Human Milk Oligosaccharides in Healthy Adults
NCT05516225
Randomized Study of Human-Milk Based Nutrition Versus Formula in Premature Infants
NCT00506584
Evaluation of Prolact-Plus Human Milk Fortifier
NCT00486590
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 1 |
Therapeutic Areas
How the Prolacta Bioscience early-phase archive is shaped
7 indexed studies, none listed as recruiting (0% open); 5 completed (71%).
Phase mix: 0 late (III/IV) vs 3 early (I/II) (early-phase heavy).
Top condition: Infant, Very Low Birth Weight (1 trial), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Prolacta Bioscience: archived-pipeline peers nationwide
Peers matched on 7 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Prolacta Bioscience sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 archived trials
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Prolacta Bioscience page
7 registered trials is a research-attention snapshot, not an endorsement of Prolacta Bioscience or any single study.
- None of Prolacta Bioscience's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Infant, Very Low Birth Weight is the condition Prolacta Bioscience studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Infant, Very Low Birth Weight trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Prolacta Bioscience pipeline card: 7 registered trials from official public datasets.Report a data error.